Chondroitin sulfate activates B cells in vitro, expands CD138+ cells in vivo, and interferes with established humoral immune responses.
about
Biocompatible complex coated with glycosaminoglycan for gene delivery.Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines.B-cell inhibition by cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies in treating murine collagen-induced arthritis.
P2860
Chondroitin sulfate activates B cells in vitro, expands CD138+ cells in vivo, and interferes with established humoral immune responses.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Chondroitin sulfate activates ...... shed humoral immune responses.
@en
Chondroitin sulfate activates ...... shed humoral immune responses.
@nl
type
label
Chondroitin sulfate activates ...... shed humoral immune responses.
@en
Chondroitin sulfate activates ...... shed humoral immune responses.
@nl
prefLabel
Chondroitin sulfate activates ...... shed humoral immune responses.
@en
Chondroitin sulfate activates ...... shed humoral immune responses.
@nl
P2093
P2860
P356
P1476
Chondroitin sulfate activates ...... shed humoral immune responses.
@en
P2093
Barbara Reich
Fabian Hermann
Hilke Brühl
Josef Cihak
Jîŕi Plachý
Kerstin Renner
Manfred Stangassinger
Manuel Rodriguez-Gomez
Matthias Mack
Nicole Goebel
P2860
P356
10.1189/JLB.1A0913-502R
P577
2014-02-20T00:00:00Z